Schematic overview of the cellular and molecular mechanisms involved in the cancer progression, including the proposed cellular and molecular mechanisms in cancer cells trajectory. AT1: alveolar type 1 cells; AT2: alveolar type 2 cells; AAH: atypical adenomatous hyperplasia; AIS: adenocarcinoma in situ; MIA: minimally invasive adenocarcinoma; IA: invasive adenocarcinoma; EMT: epithelial-mesenchymal transition

Home

Download

Statistics

Help

Contact

Center for Computational Systems Medicine
leaf

Gene summary

leaf

Malignant transformation analysis

leaf

Malignant transformation related pathway analysis

leaf

Cell-cell communication analysis

leaf

Single-cell gene regulatory network inference analysis

leaf

Somatic mutation of malignant transformation related genes

leaf

Related drugs of malignant transformation related genes

Gene: WIPI2

Gene summary for WIPI2

check button Gene summary.

Gene informationSpeciesHuman
Gene symbol

WIPI2

Gene ID

26100

Gene nameWD repeat domain, phosphoinositide interacting 2
Gene AliasATG18B
Cytomap7p22.1
Gene Typeprotein-coding
GO ID

GO:0000045

UniProtAcc

Q9Y4P8


Top

Malignant transformation analysis

check button Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells
check button Malignant transformation involving gene list.
Entrez IDSymbolReplicatesSpeciesOrganTissueAdj P-valueLog2FCMalignancy
26100WIPI2HTA11_2487_2000001011HumanColorectumSER3.68e-022.15e-01-0.1808
26100WIPI2HTA11_1938_2000001011HumanColorectumAD5.14e-044.05e-01-0.0811
26100WIPI2HTA11_78_2000001011HumanColorectumAD2.93e-033.84e-01-0.1088
26100WIPI2HTA11_347_2000001011HumanColorectumAD6.13e-144.53e-01-0.1954
26100WIPI2HTA11_411_2000001011HumanColorectumSER3.21e-036.78e-01-0.2602
26100WIPI2HTA11_3361_2000001011HumanColorectumAD5.94e-032.98e-01-0.1207
26100WIPI2HTA11_696_2000001011HumanColorectumAD2.15e-123.87e-01-0.1464
26100WIPI2HTA11_866_2000001011HumanColorectumAD8.49e-052.90e-01-0.1001
26100WIPI2HTA11_1391_2000001011HumanColorectumAD3.57e-125.53e-01-0.059
26100WIPI2HTA11_546_2000001011HumanColorectumAD4.49e-044.18e-01-0.0842
26100WIPI2HTA11_866_3004761011HumanColorectumAD1.30e-063.74e-010.096
26100WIPI2HTA11_8622_2000001021HumanColorectumSER1.44e-022.90e-010.0528
26100WIPI2HTA11_7696_3000711011HumanColorectumAD1.27e-074.19e-010.0674
26100WIPI2HTA11_6818_2000001021HumanColorectumAD7.47e-053.20e-010.0588
26100WIPI2HTA11_99999970781_79442HumanColorectumMSS5.04e-073.23e-010.294
26100WIPI2HTA11_99999965104_69814HumanColorectumMSS2.98e-023.88e-010.281
26100WIPI2HTA11_99999971662_82457HumanColorectumMSS8.54e-124.90e-010.3859
26100WIPI2HTA11_99999973899_84307HumanColorectumMSS3.20e-035.61e-010.2585
26100WIPI2HTA11_99999974143_84620HumanColorectumMSS1.66e-124.54e-010.3005
26100WIPI2LZE4THumanEsophagusESCC4.86e-068.03e-020.0811
Page: 1 2 3 4 5 6 7 8 

check button Transcriptomic changes along malignancy continuum.
TissueExpression DynamicsAbbreviation
Colorectum (GSE201348)The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.FAP: Familial adenomatous polyposis
CRC: Colorectal cancer
Colorectum (HTA11)The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.AD: Adenomas
SER: Sessile serrated lesions
MSI-H: Microsatellite-high colorectal cancer
MSS: Microsatellite stable colorectal cancer
EsophagusThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.ESCC: Esophageal squamous cell carcinoma
HGIN: High-grade intraepithelial neoplasias
LGIN: Low-grade intraepithelial neoplasias
LiverThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.HCC: Hepatocellular carcinoma
NAFLD: Non-alcoholic fatty liver disease
Oral CavityThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.EOLP: Erosive Oral lichen planus
LP: leukoplakia
NEOLP: Non-erosive oral lichen planus
OSCC: Oral squamous cell carcinoma
ProstateThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.BPH: Benign Prostatic Hyperplasia
SkinThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.AK: Actinic keratosis
cSCC: Cutaneous squamous cell carcinoma
SCCIS:squamous cell carcinoma in situ
ThyroidThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.ATC: Anaplastic thyroid cancer
HT: Hashimoto's thyroiditis
PTC: Papillary thyroid cancer
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.

Top

Malignant transformation related pathway analysis

check buttonFind out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer
check button Figure of enriched GO biological processes.
TissueDisease StageEnriched GO biological Processes
ColorectumADGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumSERGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumMSSGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumMSI-HGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumFAPGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
Page: 1 2 3 4 5 6 7 8 9 

check button Enriched GO biological processes.
GO IDTissueDisease StageDescriptionGene RatioBg Ratiopvaluep.adjustCount
GO:0022411ColorectumADcellular component disassembly147/3918443/187238.53e-106.76e-08147
GO:0016236ColorectumADmacroautophagy103/3918291/187236.76e-094.15e-07103
GO:1903008ColorectumADorganelle disassembly46/3918114/187231.81e-065.48e-0546
GO:0000422ColorectumADautophagy of mitochondrion35/391881/187234.94e-061.29e-0435
GO:0061726ColorectumADmitochondrion disassembly35/391881/187234.94e-061.29e-0435
GO:0031667ColorectumADresponse to nutrient levels138/3918474/187231.22e-052.68e-04138
GO:0061912ColorectumADselective autophagy29/391868/187234.20e-057.39e-0429
GO:0042594ColorectumADresponse to starvation63/3918197/187231.77e-042.38e-0363
GO:0071496ColorectumADcellular response to external stimulus94/3918320/187231.98e-042.64e-0394
GO:0009267ColorectumADcellular response to starvation51/3918156/187233.90e-044.44e-0351
GO:0031668ColorectumADcellular response to extracellular stimulus71/3918246/187231.86e-031.52e-0271
GO:0031669ColorectumADcellular response to nutrient levels63/3918215/187232.19e-031.73e-0263
GO:0007033ColorectumADvacuole organization53/3918180/187234.18e-032.89e-0253
GO:00224111ColorectumSERcellular component disassembly114/2897443/187231.17e-089.59e-07114
GO:00162361ColorectumSERmacroautophagy79/2897291/187231.97e-071.10e-0579
GO:00004221ColorectumSERautophagy of mitochondrion29/289781/187235.61e-062.01e-0429
GO:00617261ColorectumSERmitochondrion disassembly29/289781/187235.61e-062.01e-0429
GO:19030081ColorectumSERorganelle disassembly36/2897114/187231.22e-053.89e-0436
GO:00316671ColorectumSERresponse to nutrient levels106/2897474/187233.94e-051.00e-03106
GO:00619121ColorectumSERselective autophagy24/289768/187234.60e-051.15e-0324
Page: 1 2 3 4 5 6 7 8 9 10 11 

check button Enriched KEGG pathways.
Pathway IDTissueDisease StageDescriptionGene RatioBg Ratiopvaluep.adjustqvalueCount
hsa05010ColorectumADAlzheimer disease174/2092384/84651.82e-199.26e-185.91e-18174
hsa05016ColorectumADHuntington disease147/2092306/84651.93e-199.26e-185.91e-18147
hsa05014ColorectumADAmyotrophic lateral sclerosis164/2092364/84654.28e-181.27e-168.09e-17164
hsa05022ColorectumADPathways of neurodegeneration - multiple diseases201/2092476/84654.54e-181.27e-168.09e-17201
hsa05131ColorectumADShigellosis109/2092247/84651.09e-112.44e-101.55e-10109
hsa05017ColorectumADSpinocerebellar ataxia60/2092143/84653.78e-064.35e-052.78e-0560
hsa04140ColorectumADAutophagy - animal49/2092141/84654.58e-032.20e-021.40e-0249
hsa050101ColorectumADAlzheimer disease174/2092384/84651.82e-199.26e-185.91e-18174
hsa050161ColorectumADHuntington disease147/2092306/84651.93e-199.26e-185.91e-18147
hsa050141ColorectumADAmyotrophic lateral sclerosis164/2092364/84654.28e-181.27e-168.09e-17164
hsa050221ColorectumADPathways of neurodegeneration - multiple diseases201/2092476/84654.54e-181.27e-168.09e-17201
hsa051311ColorectumADShigellosis109/2092247/84651.09e-112.44e-101.55e-10109
hsa050171ColorectumADSpinocerebellar ataxia60/2092143/84653.78e-064.35e-052.78e-0560
hsa041401ColorectumADAutophagy - animal49/2092141/84654.58e-032.20e-021.40e-0249
hsa050162ColorectumSERHuntington disease127/1580306/84653.29e-211.37e-199.92e-20127
hsa050102ColorectumSERAlzheimer disease146/1580384/84656.52e-202.40e-181.75e-18146
hsa050222ColorectumSERPathways of neurodegeneration - multiple diseases168/1580476/84656.23e-192.07e-171.50e-17168
hsa050142ColorectumSERAmyotrophic lateral sclerosis138/1580364/84659.89e-192.99e-172.17e-17138
hsa051312ColorectumSERShigellosis87/1580247/84653.07e-107.27e-095.28e-0987
hsa050172ColorectumSERSpinocerebellar ataxia46/1580143/84656.78e-057.51e-045.45e-0446
Page: 1 2 3 4 5 6 7 8 

Top

Cell-cell communication analysis

check buttonIdentification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states
LigandReceptorLRpairPathwayTissueDisease Stage
Page: 1 

Top

Single-cell gene regulatory network inference analysis

check buttonFind out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states
TFCell TypeTissueDisease StageTarget GeneRSSRegulon Activity
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.
Page: 1 

Top

Somatic mutation of malignant transformation related genes

check buttonAnnotation of somatic variants for genes involved in malignant transformation
Hugo SymbolVariant ClassVariant ClassificationdbSNP RSHGVScHGVSpHGVSp ShortSWISSPROTBIOTYPESIFTPolyPhenTumor Sample BarcodeTissueHistologySexAgeStageTherapy TypesDrugsOutcome
WIPI2SNVMissense_Mutationrs371973214c.725N>Ap.Arg242Glnp.R242QQ9Y4P8protein_codingdeleterious(0.02)possibly_damaging(0.751)TCGA-C8-A132-01Breastbreast invasive carcinomaFemale<65I/IIUnknownUnknownSD
WIPI2SNVMissense_Mutationrs375365426c.1028C>Tp.Pro343Leup.P343LQ9Y4P8protein_codingtolerated(0.57)benign(0.012)TCGA-2W-A8YY-01Cervixcervical & endocervical cancerFemale<65I/IIChemotherapycisplatinCR
WIPI2SNVMissense_Mutationc.544N>Ap.Gly182Argp.G182RQ9Y4P8protein_codingdeleterious(0)probably_damaging(0.997)TCGA-A6-5666-01Colorectumcolon adenocarcinomaMale>=65I/IIUnknownUnknownPD
WIPI2SNVMissense_Mutationc.724N>Tp.Arg242Trpp.R242WQ9Y4P8protein_codingdeleterious(0)benign(0.104)TCGA-AA-3510-01Colorectumcolon adenocarcinomaMale>=65I/IIUnknownUnknownSD
WIPI2SNVMissense_Mutationc.1229N>Cp.Val410Alap.V410AQ9Y4P8protein_codingtolerated(0.86)benign(0)TCGA-AA-3831-01Colorectumcolon adenocarcinomaMale>=65I/IIUnknownUnknownSD
WIPI2SNVMissense_Mutationc.328N>Cp.Ile110Leup.I110LQ9Y4P8protein_codingtolerated(0.09)possibly_damaging(0.452)TCGA-AZ-6598-01Colorectumcolon adenocarcinomaFemale>=65I/IIUnknownUnknownSD
WIPI2SNVMissense_Mutationrs375365426c.1028N>Tp.Pro343Leup.P343LQ9Y4P8protein_codingtolerated(0.57)benign(0.012)TCGA-D5-6530-01Colorectumcolon adenocarcinomaMale<65I/IIUnknownUnknownSD
WIPI2SNVMissense_Mutationrs759604469c.488C>Tp.Ala163Valp.A163VQ9Y4P8protein_codingdeleterious(0.04)benign(0.245)TCGA-F4-6856-01Colorectumcolon adenocarcinomaMale<65I/IIAncillaryleucovorinCR
WIPI2insertionFrame_Shift_Insnovelc.682dupAp.Arg228LysfsTer13p.R228Kfs*13Q9Y4P8protein_codingTCGA-EI-6509-01Colorectumrectum adenocarcinomaMale<65III/IVChemotherapyfolfoxPD
WIPI2SNVMissense_Mutationrs759604469c.488C>Tp.Ala163Valp.A163VQ9Y4P8protein_codingdeleterious(0.04)benign(0.245)TCGA-A5-A0G2-01Endometriumuterine corpus endometrioid carcinomaFemale<65III/IVUnknownUnknownSD
Page: 1 2 3 4 

Top

Related drugs of malignant transformation related genes

check buttonIdentification of chemicals and drugs interact with genes involved in malignant transfromation
(DGIdb 4.0)
Entrez IDSymbolCategoryInteraction TypesDrug Claim NameDrug NamePMIDs
Page: 1